However, it is surprising that we did not observe a strong enhancement of HCC development when Rb deletion is added to MYC activation, especially given the observation that many human samples of HCC tend to harbor mutations that simultaneously activate MYC and inactivate the RB pathway [57], [58]. The gene discussed is MYC; the disease is hepatocellular carcinoma.